Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

US9193720B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• B. Narasimhulu Naidu · Durham, US
• Manoj Patel · Berlin, US
• Jeffrey Lee Romine · Meriden, US
• Denis R. St. Laurent · Newington, US
• Tao Wang · Farmington, US
• Zhongxing Zhang · Wallingford, US
• John F. Kadow · Wallingford, US

Key dates

• Filing date: Feb 11, 2015
• Grant date: Nov 24, 2015
• Expiry date: Feb 11, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The disclosure generally relates to compounds of formula I, II, III and IV, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.